Condensed Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenues | ||||
| Total revenues | $ 2,446,439 | $ 2,775,767 | $ 4,593,816 | $ 4,464,702 |
| Cost of revenues | ||||
| Total cost of revenues | 952,273 | 2,853,133 | 2,085,338 | 4,421,792 |
| Gross profit | 1,494,166 | (77,366) | 2,508,478 | 42,910 |
| Operating expenses: | ||||
| Professional fees | 384,825 | 291,425 | 677,939 | 573,184 |
| General and administrative | 327,280 | 368,220 | 572,877 | 644,849 |
| Research and development | 82,056 | 193,543 | 162,499 | 402,794 |
| Compensation and related expenses | 2,392,032 | 793,400 | 5,186,763 | 1,481,602 |
| Marketing | 57,767 | 22,861 | 85,611 | 268,033 |
| Impairment loss on intangible digital assets | 5,241,573 | 5,451,494 | ||
| Realized losses on digital asset transactions | 4,890,916 | 2,777,620 | 34,184,862 | 4,159,908 |
| Unrealized loss (gain) on digital assets | 21,419,814 | (8,793,161) | 57,104,990 | 5,737,661 |
| Total operating expenses | 34,796,263 | (4,346,092) | 103,427,035 | 13,268,031 |
| Other income (expenses): | ||||
| Interest expense | (1,601,133) | (221,894) | (3,148,992) | (221,894) |
| Change in fair value of warrant liabilities | (165,300) | 59,850 | ||
| Total other income (expenses) | (1,601,133) | (387,194) | (3,148,992) | (162,044) |
| Net income (loss) | $ (34,903,230) | $ 3,881,532 | $ (104,067,549) | $ (13,387,165) |
| Basic net income (loss) per share attributable to common stockholders | $ (0.70) | $ 0.18 | $ (2.12) | $ (0.65) |
| Diluted net income (loss) per share attributable to common stockholders | $ (0.70) | $ 0.14 | $ (2.12) | $ (0.65) |
| Basic weighted average number of common shares outstanding | 49,775,712 | 21,259,682 | 49,006,266 | 20,616,935 |
| Diluted weighted average number of common shares outstanding, basic and diluted | 49,775,712 | 27,938,660 | 49,006,266 | 20,616,935 |
| Blockchain Infrastructure Revenues [Member] | ||||
| Revenues | ||||
| Total revenues | $ 944,649 | $ 2,772,198 | $ 2,080,000 | $ 4,461,133 |
| Cost of revenues | ||||
| Total cost of revenues | 943,198 | 2,853,133 | 2,067,188 | 4,421,792 |
| DeFi Revenues [Member] | ||||
| Revenues | ||||
| Total revenues | 1,501,790 | 3,569 | 2,513,816 | 3,569 |
| Cost of revenues | ||||
| Total cost of revenues | $ 9,075 | $ 18,150 | ||
| X | ||||||||||
- Definition Impairment loss on intangible digital assets. No definition available.
|
| X | ||||||||||
- Definition Realized gains losses on digital asset currency transactions. No definition available.
|
| X | ||||||||||
- Definition Unrealized gain loss on digital assets No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|